Long-term safety and efficacy of MBA-P01 for the treatment of glabellar lines: results from a multicenter, repeated-dose, open-label extension study

被引：1

作者：

Han, Hye Sung ^{[1
]}

Kim, Won-Serk ^{[2
]}

Lee, Yang Won ^{[3
]}

Won, Chong Hyun ^{[4
]}

Lee, Wooshun ^{[5
]}

Choi, Sun Young ^{[1
]}

Kim, Beom Joon ^{[6
]}

机构：

[1] Chung Ang Univ, Coll Med, Dept Dermatol, Gwangmyeong Hosp, Anseong, Gyeonggi Do, South Korea

[2] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Dermatol, Seoul, South Korea

[3] Konkuk Univ, Sch Med, Dept Dermatol, Seoul, South Korea

[4] Univ Ulsan, Coll Med, Dept Dermatol, Asan Med Ctr, Seoul, South Korea

[5] Medytox Inc, Seoul, South Korea

[6] Chung Ang Univ, Chung Ang Univ Hosp, Dept Dermatol, Coll Med, Seoul, South Korea

来源：

JOURNAL OF DERMATOLOGICAL TREATMENT | 2024年 / 35卷 / 01期

关键词：

Glabellar lines; botulinum toxin; new botulinum toxin (MBA-P01); long-term safety; open-label extension study; TOXIN TYPE-A; BOTULINUM; PTOSIS; INJECTION;

D O I：

10.1080/09546634.2024.2418919

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Clinical trial registration information: This study is registered in ClincalTrials.gov (NCT05321979).

引用

页数：8

共 32 条

[11] Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study [J].

Murai, Hiroyuki ;

Uzawa, Akiyuki ;

Suzuki, Yasushi ;

Imai, Tomihiro ;

Shiraishi, Hirokazu ;

Suzuki, Hidekazu ;

Okumura, Meinoshin ;

O'Brien, Fanny ;

Wang, Jing-Jing ;

Fujita, Kenji P. ;

Utsugisawa, Kimiaki .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 407

[12] Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study [J].

Kestemont, Philippe ;

Hilton, Said ;

Andriopoulos, Bill ;

Prygova, Inna ;

Thompson, Catherine ;

Volteau, Magali ;

Ascher, Benjamin .

AESTHETIC SURGERY JOURNAL, 2022, 42 (03) :301-313

[13] IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study [J].

Marciniak, Christina ;

Munin, Michael C. ;

Brashear, Allison ;

Rubin, Bruce S. ;

Patel, Atul T. ;

Slawek, Jaroslaw ;

Hanschmann, Angelika ;

Hiersemenzel, Reinhard ;

Elovic, Elie P. .

ADVANCES IN THERAPY, 2019, 36 (01) :187-199

[14] Open-label, long-term extension study to evaluate the safety of clascoterone (CB-03-01) cream, 1% twice daily, in patients with acne vulgaris [J].

Eichenfield, Lawrence ;

Hebert, Adelaide ;

Gold, Linda Stein ;

Cartwright, Martina ;

Fragasso, Enrico ;

Moro, Luigi ;

Mazzetti, Alessandro .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) :477-485

[15] Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study [J].

Cutler, Andrew J. ;

Durgam, Suresh ;

Wang, Yao ;

Migliore, Raffaele ;

Lu, Kaifeng ;

Laszlovszky, Istvan ;

Nemeth, Gyorgy .

CNS SPECTRUMS, 2018, 23 (01) :39-50

[16] Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study [J].

Dressler, Dirk ;

Rychlik, Reinhard ;

Kreimendahl, Fabian ;

Schnur, Nicole ;

Lambert-Baumann, Judith .

BMJ OPEN, 2015, 5 (12)

[17] Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study [J].

Tanaka, Yoshiya ;

Curtis, Paula ;

DeRose, Kathleen ;

Kurrasch, Regina ;

Kinoshita, Kyoko ;

Tanaka, Rika ;

Yamazaki, Yumi ;

Roth, David A. .

MODERN RHEUMATOLOGY, 2023, 33 (01) :122-133

[18] IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study [J].

Trevidic, Patrick ;

Connolly, Simon A. ;

Biwer, Bernard ;

Ellers-Lenz, Barbara ;

Harrington, Laura S. ;

Kestemont, Philippe ;

Noah, Ernst M. ;

Sattler, Gerhard ;

Weissenberger, Petra ;

Kerscher, Martina .

DERMATOLOGIC SURGERY, 2017, 43 :S285-S292

[19] Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study) [J].

Pongracic, Jacqueline A. ;

Gagnon, Remi ;

Sussman, Gordon ;

Siri, Dareen ;

Oriel, Roxanne C. ;

Brown-Whitehorn, Terri F. ;

Anvari, Sara ;

Berger, William E. ;

Bird, J. Andrew ;

Chan, Edmond S. ;

Chinthrajah, R. Sharon ;

Chong, Hey J. ;

Fineman, Stanley M. ;

Fleischer, David M. ;

Gonzalez-Reyes, Erika ;

Kim, Edwin H. ;

Lanser, Bruce J. ;

MacGinnitie, Andrew ;

Mehta, Hemalini ;

Petroni, Daniel ;

Rupp, Ned ;

Schneider, Lynda C. ;

Scurlock, Amy M. ;

Sher, Lawrence D. ;

Shreffler, Wayne G. ;

Sindher, Sayantani B. ;

Wood, Robert ;

Yang, William H. ;

Sampson, Hugh A. ;

Bois, Timothee ;

Green, Todd D. ;

Campbell, Dianne E. ;

Bee, Katharine J. ;

Begin, Philippe .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2025, 13 (05) :1190-1200.e3

[20] LONG-TERM EFFICACY AND SAFETY OF ABOBOTULINUMTOXINA SOLUTION FOR THE TREATMENT OF MODERATE-TO-SEVERE GLABEL LAR LINES: A PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED AND OPEN-LABEL REPEAT INJECTION STUDY [J].

Kestemont, Philippe ;

Hilton, Said ;

Andriopoulos, Bill ;

Prygova, Inna ;

Thompson, Catherine ;

Volteau, Magali ;

Ascher, Benjamin .

TOXICON, 2021, 190 :S40-S40

← 1 2 3 4 →